SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-019848
Filing Date
2022-08-11
Accepted
2022-08-10 17:37:43
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20220630_10q.htm   iXBRL 10-Q 686882
2 EXHIBIT 31.1 ex_405323.htm EX-31.1 12458
3 EXHIBIT 31.2 ex_405324.htm EX-31.2 12550
4 EXHIBIT 32.1 ex_405325.htm EX-32.1 4771
5 EXHIBIT 32.2 ex_405326.htm EX-32.2 4748
11 pic1.jpg GRAPHIC 38750
  Complete submission text file 0001437749-22-019848.txt   3877301

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20220630.xsd EX-101.SCH 42581
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20220630_def.xml EX-101.DEF 274518
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20220630_lab.xml EX-101.LAB 217187
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20220630_pre.xml EX-101.PRE 297619
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20220630_cal.xml EX-101.CAL 29192
57 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20220630_10q_htm.xml XML 522753
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 221152917
SIC: 2834 Pharmaceutical Preparations